ArticleCureus2025

A Prospective Evaluation of Tocilizumab in Patients With Rheumatoid Arthritis Refractory to Conventional Disease-Modifying Anti-Rheumatic Medications (DMARDs).

Jazba Yousaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.